Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

about

Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic

P2860

Q58545262-92D40E73-79E5-4D50-A07A-E138404A5CFD

P2860

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

Item

http://www.wikidata.org/entity/Q47140416

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@en

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@nl

type

Item

label

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@en

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@nl

prefLabel

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@en

Cebranopadol, a Mixed Opioid A ...... pioid and Mu Opioid Receptors.

@nl

P1476

Cebranopadol, a Mixed Opioid A ...... Opioid and Mu Opioid Receptors

@en

P2093

Qianwei Shen

http://www.w3.org/2001/XMLSchema#string

Roberto Ciccocioppo

http://www.w3.org/2001/XMLSchema#string

Yulin Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system

Role of kappa-opioid receptors in stress and anxiety-related behavior.

Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse

A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration

Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)

Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist

Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice

New treatments for cocaine dependence: a focused review

Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

P304

234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPSYT.2017.00234

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nazzareno Cannella

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29180970

http://www.w3.org/2001/XMLSchema#string

P921

opioid

nociceptin

P932

5693905

http://www.w3.org/2001/XMLSchema#string

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

about

P2860

P2860

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932